Angel Funded Health Care Startups
Across these 24 most recent angel rounds in health care, one disclosed deal stands apart: MYZONE’s $17M round (2022-01-18) is far above the rest of the dis…
Across these 24 most recent angel rounds in health care, one disclosed deal stands apart: MYZONE’s $17M round (2022-01-18) is far above the rest of the disclosed amounts, which cluster between $300K and $3M (with several in the $180K–$1M range). The lower-disclosed end is also visible: Medity’s $810K (2023-09-11) sits well above the smallest disclosed amounts, while threesixfive (365.) reports $0K (2023-04-01), making it the only “floor” in disclosed values.
Date concentration appears at mid-2022 and mid-2023: there are multiple rounds in 2022-03 (BioStress Lab $200K on 2022-03-28; The Flume Catheter Company Ltd $3M on 2022-03-21) and several in late 2023 (e.g., Medity $810K on 2023-09-11; TEN $180K on 2023-11-03; hoop’s category includes 2023-11-23 only with undisclosed). Geographically, the list spans the US, UK, India, Canada, Egypt, Turkey, Spain, Australia, Switzerland, and Brazil, with India appearing repeatedly (e.g., Symbionic 2025-03-19; Moderate 2025-02-20; TEN 2023-11-03; Ubreathe 2023-02-15), though most locations are country-specific rather than multiple cities in the same metro. Rounds run from 2021-08-10 (Cyon Equipamentos) through the most recent entry on 2025-08-01 (Higher Powers).
Most recent rounds
24 shownRelated listings
Frequently asked
Which disclosed round is the clearest outlier in this health-care angel set, and how does it compare to the next tier?
MYZONE’s $17M round on 2022-01-18 is the only disclosed amount in the high single-digit millions; the next-largest disclosed amounts are $3M (The Flume Catheter Company Ltd, 2022-03-21) and $1M (Obstetrx, 2021-08-20; plus Terappin at $1M on 2022-05-11), placing most other disclosed rounds below $1M–$500K.
How concentrated are dates, especially around mid-2022 and late-2023?
There’s a tight cluster in March 2022 with two disclosed rounds in quick succession: The Flume Catheter Company Ltd ($3M) on 2022-03-21 and BioStress Lab ($200K) on 2022-03-28. Late 2023 also shows multiple entries in a short run: Medity ($810K) on 2023-09-11, TEN ($180K) on 2023-11-03, and Tagda Raho (2023-11-23, undisclosed).
Do any geographies or countries appear repeatedly enough to suggest a hub effect in this table?
India is the most frequent country in the rows: Symbionic (Chennai, 2025-03-19, $50K), Moderate (Hyderabad, 2025-02-20, $120K), Abhay Health (Haryana, 2024-07-19, undisclosed), TEN (Hyderabad, 2023-11-03, $180K), Ubreathe (Gurgaon, 2023-02-15, $180K), and Flebo.in (Gurgaon, 2022-04-18, undisclosed). Other countries appear once or twice (e.g., the UK with My Meno in 2024-10-04 and Medity is Spain, not UK).
What does the stage disclosure pattern look like in this list: undisclosed vs disclosed amounts?
While every row is labeled Angel, disclosed amounts are missing in multiple cases: My Meno (2024-10-04), Abhay Health (2024-07-19), hoop (2024-07-03), Tagda Raho (2023-11-23), Leynek Medical (2023-05-30), Aepsy (2022-10-26), RecovHub (2022-07-20), and Flebo.in (2022-04-18) show undisclosed. threesixfive (365.) reports $0K on 2023-04-01, which differs from “undisclosed” but still sits at the bottom of disclosed values.
Which entries fall closest to the top of the date range (most recent) and what are their disclosed sizes?
The most recent round is Higher Powers (2025-08-01) at $300K. The next two most recent disclosed rounds are Symbionic (2025-03-19, $50K) and Moderate (2025-02-20, $120K), placing the newest disclosed deals in the $50K–$300K band, well below the segment outlier MYZONE’s $17M (2022-01-18).
Are there any “floor” values that should be treated differently from undisclosed entries?
Yes: threesixfive (365.) lists $0K (2023-04-01). Because that is explicitly disclosed as $0K, it’s distinct from rows marked undisclosed such as My Meno (2024-10-04) and Abhay Health (2024-07-19), which provide no amount.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.